Fora Capital, LLC Harmony Biosciences Holdings, Inc. Transaction History

Fora Capital, LLC

  • $789 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$33.54 - $52.15 $253,629 - $394,358
-7,562 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$33.14 - $51.13 $250,604 - $386,645
7,562 New
7,562 $377,000
Q3 2021

Nov 15, 2021
SELL
$25.68 - $38.61 $21,442 - $32,239
-835 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$25.96 - $33.44 $21,676 - $27,922
835 New
835 $24 Million

Others Institutions Holding HRMY

# of Institutions
243
Shares Held
45.2M
Call Options Held
108K
Put Options Held
49.2K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.04B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Fora Capital, LLC Portfolio

Follow Fora Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email